Taking a new TAK on TAT transactivation

Genes and Development

Volumn 11, Issue 20, 1997, Pages 2593-2599

  Jones, Katherine A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030774549     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.20.2593     Document Type: Review

References (51)

1. Akoulitchev, S., T. Makela, R. Weinberg, and D. Reinberg. 1995. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature 377: 557-560.
2. Alonso, A., T. Cujec, and B. Peterlin. 1994. Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J. Virol. 66:6505-6513.
3. Bentley, D. 1995. Regulation of transcriptional elongation by RNA polymerase II. Curr. Opin. Genet. Dev. 5: 210-216.
4. Blair, W., R. Fridell, and B. Cullen. 1996. Synergistic enhancement of both initiation and elongation by acidic transcription activation domains. EMBO J. 15: 1658-1665.
5. Blau, J., H. Xiao, S. McCracken, P. O'Hare, J. Greenblatt, and D. Bentley. 1996. Three functional classes of transcriptional activation domains. Mol. Cell. Biol. 16: 2044-2055.
6. Chun, R. and K. Jeang. 1996. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotrophic virus I and HIV-1. J. Biol. Chem. 271: 27888-27894.
7. Cujec, T., H. Cho, E. Maldonado, J. Meyer, D. Reinberg, and B. Peterlin. 1997a. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17: 1817-1823.
8. Cujec, T., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. Morgan, and B. Peterlin. 1997b. The HIV trans-activator Tat binds to the CDK-activating kinase (CAK) and activates the phosphorylation of the C-terminal domain of RNA polymer-ase II. Genes & Dev. (this issue).
9. Dahmus, M. 1996. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271: 19009-19012.
10. Dvir, A., K. Garrett, C. Chalut, J.-M. Egly, J. Conaway, and R. Conaway. 1996. A role for ATP and TFIIH in activation of the RNA polymerase II preinitiation complex prior to transcription initiation. J. Biol. Chem. 271: 7245-7248.
11. Dvir, A., R. Conaway, and J. Conaway. 1997. A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes. Proc. Natl. Acad. Sci. 94: 9006-9010.
12. Garcia-Martinez, L., D. Ivanov, and R. Gaynor. 1997a. Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem. 272:6951-6958.
13. Garcia-Martinez, L., G. Mavankal, J. Neveu, W. Lane, D. Ivanov, and R. Gaynor. 1997b. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16: 2836-2850.
14. Garriga, J., X. Mayol, and X. Grana. 1996. The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem. J. 319: 293-298.
15. Gold, M., J.-P. Tassan, E. Nigg, A. Rice, and C. Herrmann. 1996. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8. Nucleic Acids Res. 24: 3771-3777.
16. Goodrich, J. and R. Tjian. 1994. Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell 77: 145-156.
17. Grana, X., A. De Luca, N. Sang, Y. Fu, P. Claudio, J. Rosenblatt, D. Morgan, and A. Giordano. 1994. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. 91: 3834-3838.
18. Greenblatt, J., J.R. Nodwell, and S.W. Mason. 1993. Transcriptional antitermination. Nature 364: 401-416.
19. Hamy, F., E. Felder, G. Heizmann, J. Lazdins, F. Aboul-ela, G. Varani, J. Karn, and T. Klimkai. 1997. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. Proc. Natl. Acad. Sci. 94: 3548-3553.
20. Hart, C., J. Galphin, M. Westhafer, and G. Schochetman. 1993. TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J. Virol. 67: 5020-5024.
21. Herrmann, C. and A. Rice. 1993. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197:601-608.
22. _. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69: 1612-1620.
23. Herrmann, C., M. Gold, and A. Rice. 1996. Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain. Nucleic Acids Res. 24: 501-508.
24. Hunter, T. 1997. Oncoprotein networks. Cell 88: 333-346.
25. Jones, K. and B. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63: 717-743.
26. Keen, N., M. Gait, and J. Karn. 1996. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. 93: 2505-2510.
27. Keen, N., M. Churcher, and J. Karn. 1997. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16: 5260-5272.
28. Kephart, D., N. Marshall, and D. Price. 1992. Stability of Drosophila RNA polymerase II elongation complexes in vitro. Mol. Cell. Biol. 12: 2067-2077.
29. Li, C., D. Friedman, C. Wang, V. Metelev, and A. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268: 429-431.
30. Mancebo, H., G. Lee, J. Flygare, J. Tornassini, P. Luu, Y. Zhu, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes & Dev. (this issue).
31. Marciniak, R. and P. Sharp. 1991. HIV-1 Tat promotes formation of more-processive elongation complexes. EMBO J. 10: 4189-1196.
32. Marshall, N. and D. Price. 1992. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12: 2078-2090.
33. _. 1995. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270: 12335-12338.
34. Marshall, N., J. Peng, Z. Xie, and D. Price. 1996. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271: 27176-27183.
35. Mavankal, G., S. Ignatius Ou, H. Oliver, D. Sigman, and R. Gaynor. 1996. Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. 93: 2089-2094.
36. Okamoto, H., C. Sheline, J. Corden, K. Jones, and B. Peterlin. 1996. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. 93: 11575-11579.
37. Ott, M., S. Emiliani, C. Van Lint, G. Herbein, J. Lovett, N. Chirmule, T. McCloskey, S. Pahwa, and E. Verdin. 1997. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275: 1481-1485.
38. Parada, C. and R. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxyl-terminal domain. Nature 384:375-378.
39. Pendergrast, P. and N. Hernandez. 1997. RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at human immunodeficiency virus type 1 long terminal repeat. J. Virol. 71: 910-917.
40. Pessler, F., P. Pendergrast, and N. Hernandez. 1997. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol. Cell. Biol. 17: 3786-3798.
41. Poon, R. and T. Hunter. 1995. Innocent bystanders or chosen collaborators? Curr. Biol. 5: 1243-1247.
42. Svejstrup, J., P. Vichi, and J.-M. Egly. 1996. The multiple roles of transcription/repair factor TFIIH. Trends Biochem. Sci. 21: 346-350.
43. Svejstrup, J., Y. Li, J. Fellows, A. Gnatt, S. Bjorklund, and R. Kornberg. 1997. Evidence for a mediator cycle at the initiation of transcription. Proc. Natl. Acad. Sci. 94: 6075-6078.
44. Tao, J., L. Chen, and A. Frankel. 1997. Dissection of the proposed base triple in human immunodeficiency virus TAR RNA indicates the importance of the Hoogsteen interaction. Biochemistry 36: 3491-3495.
45. Xie, Z. and D.H. Price. 1996. Purification of an RNA polymerase II transcript release factor from Drosophila J. Biol. Chem. 271: 11043-11046.
46. Yang, X., C. Herrmann, and A. Rice. 1996. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70: 4576-45584.
47. Yankulov, K., M. Pandes, S. McCracken, D. Bouchard, and D. Bentley. 1996. TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes. Mol. Cell. Biol. 16:3291-3299.
48. Zawel, L., K.P. Kumar, and D. Reinberg. 1995. Recycling of the general transcription factors during RNA polymearse II transcription. Genes & Dev. 9: 1479-1490.
49. Zhou, Q. and P.A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14: 321-328.
50. _. 1996. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274: 605-610.
51. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. Mathews, and D. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes & Dev. (this issue).